B超引导下冷循环微波刀治疗原发性肝癌的临床价值.docxVIP

B超引导下冷循环微波刀治疗原发性肝癌的临床价值 田慧 徐庆杰 和振坤(河南大学淮河医院 河南开封475000) 【中图分类号】R735.7【文献标识码】A【文章编号】1672-5085 (2013) 30-0054-03 【摘要】目的 观察B超引导下冷循环微波刀治疗原发性肝癌的临床效果。 方法2006年12月至2012年1月于我科诊治因各种原因无法进行手术的PLC 患者，共82例，行B超引导下冷循环微波刀，观察术中、术后并发症发生情况， 动态监测术后AFP及肝功能变化、生活质量及近期生存率。结果 木组患者在术 中、术后均未出现严重并发症，患者生存质量、临床症状、AFP等均明显改善, 术后1、2、3年牛存率分别为81.3%、62.7%和39.8%, 1年牛存率较外科手术 切除相近，2、3年牛存率较其有所升高。结论B超引导下冷循环微波刀作为治 疗PLC的一门新技术，能切实改善患者的牛存质量、临床症状，提高术后牛存率。 【关键词】B超引导 冷循环微波刀 原发性肝癌 Clinical value of B ultrasoguided psychro-circulation percutaneous microwave coagulation therapy in treating Primary liver cancer(PLC). Tian Hui Xu Qing-jie He Zhen-kun * * Huaihe Hospital of Henan University in Kaifeng, Henan 475000 [Abstract] ObjectiveTo explore the clinical value of B ultrasound-guided psychro-circulation percutaneous microwave coagulation therapy in treating Primary liver cancer. Methods 82 cases with PLC who could not undergo surgery for various reasons were selected to receive B ultrasound-guided psychro-circulation percutaneous microwave coagulation therapy from Dec.2006 to Jan.2012 in our hospital. The pre-and postoperative clinical symptomsalpha fetoprotein(AFP) levels、 liver function and quality of life were detected.The postoperative 1.2 and 3 Y survival rate of those patients was followed up and recorded.Results No severe complications occurred in this series? patients quality of life clinical symptoms and AFP were obviously improved.The postoperative 1, 2 and 3 Y survival rate was 81.3%、62.7% and 39.8%. Conclusions psychro-circulation percutaneous microwave coagulation therapy is an efective method for treating PLC, and it is especially suitable for ino perable patie nts, because of its few complicati ons and con venie nt performs nee. [Key words] B ultrasound-guided psychro-circulation percutaneous microwave coagulation therapy PLC 原发性肝癌(Primary liver cancer, PLC)是我国常见的恶性肿瘤之一，0前手 术切除仍是肝癌治疗的首选手段，但因其起病隐匿，绝大多数患者确诊时已属于 中晚期，手术切除机会只有10%-15%。临床实践中更多的患者需要手术切除以 外的治疗方法，其中冷循环微波刀属微创消融治疗，通过微波使肿瘤凝固、脱水 坏死达到治疗目的，更易达到与外科手术类